AstraZeneca's Bob Li on the MARS mission to eliminate cancer

Bob Li, AstraZeneca's Senior Vice President, Global Head of Medical Affairs, Oncology, on why only seven percent of cancer patients get access to clinical trials, and what decentralized trials, AI, and international collaboration could do to change that within a decade.
See mckinsey.com/privacy-policy for privacy information